Spectrum Pharmaceuticals, Inc. (SPPI) Tops Q2 EPS by 18c

Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) reported Q2 EPS of $0.09, $0.18 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $46.9 million versus the consensus estimate of $41.5 million.

For earnings history and earnings-related data on Spectrum Pharmaceuticals, Inc. (SPPI) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Brinker Int'l (EAT) PT Raised to $260 at DA Davidson, Neutral Rating Maintained
• Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c